APA (7th ed.) Citation

JS, F., L, T., XE, B., MC, R., RT, B., JE, C., . . . D, A. (2023). γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer. Science advances, 9(18), eadf0108. https://doi.org/10.1126/sciadv.adf0108

Chicago Style (17th ed.) Citation

JS, Frieling, et al. "γδ-Enriched CAR-T Cell Therapy for Bone Metastatic Castrate-resistant Prostate Cancer." Science Advances 9, no. 18 (2023): eadf0108. https://doi.org/10.1126/sciadv.adf0108.

MLA (9th ed.) Citation

JS, Frieling, et al. "γδ-Enriched CAR-T Cell Therapy for Bone Metastatic Castrate-resistant Prostate Cancer." Science Advances, vol. 9, no. 18, 2023, p. eadf0108, https://doi.org/10.1126/sciadv.adf0108.